Rifaximin is an antibiotic used to treat irritable bowel syndrome with diarrhea, reduce the risk of overt hepatic encephalopathy recurrence in adults, and treat travelers’ diarrhea caused by noninvasive strains of Escherichia coli.

It has a broad spectrum of activity against both gram-negative and gram-positive anaerobic and aerobic bacteria.